Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sechter

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
La Revue Du Praticien|November 1, 1994
[Value of plasma assays of psychotropic drugs]T François, B Bonin, S Vandel, et al.
Biological Psychiatry|August 1, 1986
Lack of seasonal variation in platelet [3H]imipramine binding in humansA M Galzin, H Lôo, D Sechter, et al.
Pharmacopsychiatria|January 1, 1982
High-affinity 3H-imipramine binding: a new biological marker in depressionS Z Langer, E Zarifian, M Briley, et al.
Archives of General Psychiatry|October 1, 1986
Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depressionS Z Langer, D Sechter, H Loo, et al.
L'Encephale|July 4, 2008
[The therapeutic alliance in the initial stages of the management of depression by the general practitioner]P Frémont, A Gérard, D Sechter, et al.
Life Sciences|July 20, 1981
High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disordersS Z Langer, E Zarifian, M Briley, et al.
Psychopharmacology|January 1, 1981
High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteersR Raisman, D Sechter, M S Briley, et al.
Neuropharmacology|December 1, 1980
[3H]-Imipramine binding in human platelets: a new biochemical parameter in depressionM S Briley, R Raisman, D Sechter, et al.
L'Encephale|June 30, 2000
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]K Reggiani, P Vandel, E Haffen, et al.
Science (New York, N.Y.)|July 11, 1980
Tritiated imipramine binding sites are decreased in platelets of untreated depressed patientsM S Briley, S Z Langer, R Raisman, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
La Revue Du Praticien|November 1, 1994
[Value of plasma assays of psychotropic drugs]T François, B Bonin, S Vandel, et al.
Biological Psychiatry|August 1, 1986
Lack of seasonal variation in platelet [3H]imipramine binding in humansA M Galzin, H Lôo, D Sechter, et al.
Pharmacopsychiatria|January 1, 1982
High-affinity 3H-imipramine binding: a new biological marker in depressionS Z Langer, E Zarifian, M Briley, et al.
Archives of General Psychiatry|October 1, 1986
Electroconvulsive shock therapy and maximum binding of platelet tritiated imipramine binding in depressionS Z Langer, D Sechter, H Loo, et al.
L'Encephale|July 4, 2008
[The therapeutic alliance in the initial stages of the management of depression by the general practitioner]P Frémont, A Gérard, D Sechter, et al.
Life Sciences|July 20, 1981
High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disordersS Z Langer, E Zarifian, M Briley, et al.
Psychopharmacology|January 1, 1981
High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteersR Raisman, D Sechter, M S Briley, et al.
Neuropharmacology|December 1, 1980
[3H]-Imipramine binding in human platelets: a new biochemical parameter in depressionM S Briley, R Raisman, D Sechter, et al.
L'Encephale|June 30, 2000
[Extrapyramidal side effects of neuroleptic and antidepressant treatment: assessment of potential risk factors through CYP2D6 genetic polymorphism]K Reggiani, P Vandel, E Haffen, et al.
Science (New York, N.Y.)|July 11, 1980
Tritiated imipramine binding sites are decreased in platelets of untreated depressed patientsM S Briley, S Z Langer, R Raisman, et al.
Pageof 9